Around 50 countries are in talks with Moscow on deliveries of Russia's coronavirus drug Areplivir, the CEO of pharmaceutical company Promomed that developed the drug told Sputnik on Thursday.
"These are South American, African and Arab countries. The interest in the medication has started growing, as reports confirming its efficiency have been released", Andrey Mladentsev said.
According to the Promomed chief, the 50 countries engaged in negotiations include Brazil, Vietnam, Guatemala, Georgia, the Dominican Republic, Iraq, Egypt, Spain, Kazakhstan, Kenya, Bahrain, Kyrgyzstan, Mexico, Peru, Saudi Arabia, Serbia, Lebanon, India, Syria, Uganda, Tanzania, Rwanda, Burundi, South Sudan, Ghana, Cote d'Ivoire, Togo, Burkina Faso, Mali, Benin, Nigeria, Oman, the United Arab Emirates, Qatar, Kuwait, Iran, Colombia, Argentina, Chile, Ecuador, Paraguay, Macedonia, Slovenia, Bulgaria and South Africa.
Promomed CEO Andrey Mladentsev earlier stated that the foreign shipments of Areplirivr are suspended amid high demand in Russia.